Company registration number:
Shires Pharmacies Limited
for the Period from 1 June 2022 to 30 November 2022
Shires Pharmacies Limited
Contents
Company Information |
|
Balance Sheet |
|
Notes to the Financial Statements |
Shires Pharmacies Limited
Company Information
Director |
Mr P Cattee |
Registered office |
|
Auditors |
|
Shires Pharmacies Limited
(Registration number: 03317302)
Balance Sheet as at 30 November 2022
Note |
30 November |
(Unaudited) |
|
Fixed assets |
|||
Intangible assets |
- |
|
|
Tangible assets |
- |
|
|
- |
|
||
Current assets |
|||
Stocks |
- |
|
|
Debtors |
- |
|
|
Cash at bank and in hand |
- |
|
|
- |
|
||
Creditors: Amounts falling due within one year |
- |
( |
|
Net current assets |
- |
|
|
Total assets less current liabilities |
- |
|
|
Creditors: Amounts falling due after more than one year |
- |
( |
|
Provisions for liabilities |
- |
( |
|
Net assets |
- |
|
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Capital redemption reserve |
|
|
|
Retained earnings |
( |
|
|
Shareholders' funds |
- |
|
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
......................................... |
Shires Pharmacies Limited
Notes to the Financial Statements for the Period from 1 June 2022 to 30 November 2022
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
England
These financial statements were authorised for issue by the
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention. The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The company ceased to trade on 31 August 2022 when it's trade, assets and liabilities were transferred to the parent company PCT Healthcare Limited.
Audit report
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Tax
The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
Shires Pharmacies Limited
Notes to the Financial Statements for the Period from 1 June 2022 to 30 November 2022
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.
Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
Asset class |
Depreciation method and rate |
Short leasehold |
straight line over the period of lease |
Fixtures and fittings |
20% reducing balance |
Motor vehicles |
25% reducing balance |
Computer equipment |
20% reducing balance |
Goodwill
Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.
Amortisation
Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:
Asset class |
Amortisation method and rate |
NHS Licences |
20 years straight line |
Stocks
stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete ans slow moving items.
Shires Pharmacies Limited
Notes to the Financial Statements for the Period from 1 June 2022 to 30 November 2022
Leases
Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.
Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.
Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.
Defined contribution pension obligation
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit and loss in the period to which they related.
Staff numbers |
The average number of persons employed by the company (including the director) during the period, was
Intangible assets |
NHS pharmacy licenses |
Total |
|
Cost or valuation |
||
At 1 June 2022 |
|
|
At 30 November 2022 |
|
|
Amortisation |
||
Impairment |
|
|
At 30 November 2022 |
|
|
Carrying amount |
||
At 30 November 2022 |
- |
- |
At 31 May 2022 |
|
|
Shires Pharmacies Limited
Notes to the Financial Statements for the Period from 1 June 2022 to 30 November 2022
Tangible assets |
Land and buildings |
Furniture, fittings and equipment |
Motor vehicles |
Total |
|
Cost or valuation |
||||
At 1 June 2022 |
|
|
|
|
Acquired through business combinations |
( |
( |
( |
( |
At 30 November 2022 |
- |
- |
- |
- |
Depreciation |
||||
At 1 June 2022 |
|
|
|
|
Charge for the period |
|
|
|
|
Eliminated on disposal |
( |
( |
( |
( |
At 30 November 2022 |
- |
- |
- |
- |
Carrying amount |
||||
At 30 November 2022 |
- |
- |
- |
- |
At 31 May 2022 |
|
|
|
|
Debtors |
30 November |
(Unaudited) |
|
Trade debtors |
- |
|
Prepayments and accrued income |
- |
|
Other debtors |
- |
|
- |
|
Shires Pharmacies Limited
Notes to the Financial Statements for the Period from 1 June 2022 to 30 November 2022
Creditors |
Creditors: amounts falling due within one year
30 November |
(Unaudited) |
||
Due within one year |
|||
Loans and borrowings |
- |
|
|
Trade creditors |
- |
|
|
Taxation and social security |
- |
|
|
Other creditors |
- |
|
|
- |
|
Creditors: amounts falling due after more than one year
30 November |
(Unaudited) |
||
Due after one year |
|||
Loans and borrowings |
- |
|
Parent and ultimate parent undertaking |
The company's immediate parent is
The parent of the largest group in which these financial statements are consolidated is
The address of PCT Healthcare (Holdings) Limited is: